Neogenomics (NEO) Capital Expenditures Growth (1y) (2011 - 2026)
Neogenomics (NEO) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -33.33% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -10.56% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 1.48% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 0.92% |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | 11.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.11% |
| Dec 31, 2025 | 38.76% |
| Sep 30, 2025 | -23.01% |
| Jun 30, 2025 | -51.65% |
| Mar 31, 2025 | -19.43% |
| Dec 31, 2024 | -109,323.08% |
| Sep 30, 2024 | 164.34% |
| Jun 30, 2024 | -19.51% |
| Mar 31, 2024 | 375.72% |
| Dec 31, 2023 | 99.89% |
| Sep 30, 2023 | -313.99% |
| Jun 30, 2023 | 57.83% |
| Mar 31, 2023 | -85.72% |
| Dec 31, 2022 | -305.80% |
| Sep 30, 2022 | -47.63% |
| Jun 30, 2022 | -70.67% |
| Mar 31, 2022 | 294.95% |
| Dec 31, 2021 | 176.92% |
| Sep 30, 2021 | -0.84% |
| Jun 30, 2021 | 1,680.23% |